Evidence map›Paper›PMID 30778669›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2019

Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors.

Maxime Caru, Denis Corbin, Delphine Périé, Valérie Lemay, Jacques Delfrate, Simon Drouin, Laurence Bertout, Maja Krajinovic, Caroline Laverdière, Gregor Andelfinger and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Maxime CaruLaboratoire de Physiopathologie de l'EXercice (LPEX), Département de Kinésiologie, Université de Montréal, CEPSUM, 2100, boulevard Édouard Montpetit, H3C 3J7, Montreal, QC, Canada. maxime.caru@umontreal.ca.ORCID http://orcid.org/0000-0003-2904-9185
Denis CorbinLaboratoire de Physiopathologie de l'EXercice (LPEX), Département de Kinésiologie, Université de Montréal, CEPSUM, 2100, boulevard Édouard Montpetit, H3C 3J7, Montreal, QC, Canada.
Delphine PériéSainte-Justine University Health Center, Research Center, Montreal, QC, Canada.
Valérie LemayLaboratoire de Physiopathologie de l'EXercice (LPEX), Département de Kinésiologie, Université de Montréal, CEPSUM, 2100, boulevard Édouard Montpetit, H3C 3J7, Montreal, QC, Canada.
Jacques DelfrateSainte-Justine University Health Center, Research Center, Montreal, QC, Canada.
Simon DrouinSainte-Justine University Health Center, Research Center, Montreal, QC, Canada.
Laurence BertoutSainte-Justine University Health Center, Research Center, Montreal, QC, Canada.
Maja KrajinovicSainte-Justine University Health Center, Research Center, Montreal, QC, Canada.
Caroline LaverdièreSainte-Justine University Health Center, Research Center, Montreal, QC, Canada.
Gregor AndelfingerSainte-Justine University Health Center, Research Center, Montreal, QC, Canada.
Daniel SinnettSainte-Justine University Health Center, Research Center, Montreal, QC, Canada.
Daniel CurnierLaboratoire de Physiopathologie de l'EXercice (LPEX), Département de Kinésiologie, Université de Montréal, CEPSUM, 2100, boulevard Édouard Montpetit, H3C 3J7, Montreal, QC, Canada.
Centre Hospitalier Universitaire Sainte-Justine · CAUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsAcute lymphoblastic leukemia (ALL) is one of the leading malignancies in children worldwide. The cardiotoxicity of anti-cancer treatments leads to a dysfunction of the cardiac autonomic nervous system. Protection strategies, with dexrazoxane treatments, were used to counter these adverse effects. The aim of this study was to investigate the effects of the treatments on the cardiac autonomic nervous system. METHODS AND

resultsA total of 203 cALL survivors were included in our analyses and were classified into 3 categories based on the prognostic risk group: standard risk, high risk with and without dexrazoxane. A 24-h Holter monitoring was performed to study the cardiac autonomic nervous system. The frequency domain heart rate variability (HRV) was used to validate the cardiac autonomic nervous system modifications. Other analyses were performed using linear HRV indexes in the time domain and non-linear indexes. A frequency domain HRV parameters analysis revealed significant differences on an overall time-period of 24 h. A repeated measures ANOVA indicated a group-effect for the low frequency (p = 0.029), high frequency (p = 0.03) and LF/HF ratio (p = 0.029). Significant differences in the time domain and in the non-linear power spectral density HRV parameters were also observed.

conclusionAnti-cancer treatments induced significant changes in the cardiac autonomic nervous system. The HRV was sensitive enough to detect cardiac autonomic nervous system alterations depending on the cALL risk category. Protection strategies (i.e., dexrazoxane treatments), which were used to counter the adverse effects of doxorubicin, could prevent changes observed in the cardiac autonomic nervous system.

Indexed as

AdolescentAdultAntibiotics, AntineoplasticAutonomic Nervous SystemBlood PressureCancer SurvivorsCardiotoxicityDoxorubicinElectrocardiography, AmbulatoryHeart RateHumansPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisRisk FactorsYoung AdultAntibiotics, AntineoplasticDoxorubicinAcute lymphoblastic leukemiaCardiac autonomic nervous systemDoxorubicin treatmentsElectrophysiologyHeart rate variability

Identifiers

PMID30778669
OpenAlexW2916959017

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.